ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Vitamin D supplements, sleep could help manage pain

Bacopa: The Herb That May Increase Your Brain Power

Eat More Yogurt and Avoid Osteoporosis

Lilac Oil: More Than Just for Fragrance

Coffee, herbal tea may help prevent liver fibrosis

Crafty Uses for Carrot Seed Oil

Higher omega 3 levels linked to improved brain blood flow

Curcumin, resveratrol, ursolic acid show promise against prostate cancer

Olive oil compound could help protect against brain cancer

Probiotic use linked to improved symptoms of depression

 
Print Page
Email Article

NSAIDs Decrease Alzheimer's Plaque-Forming Protein Without Adverse Effects

  [ 15 votes ]   [ Discuss This Article ]
www.ProHealth.com • November 14, 2001




New research at the University of California, San Diego (UCSD) and the Mayo Clinic, Jacksonville, Fla, shows nonsteroidal anti-inflammatory drugs (NSAIDs) use a novel mechanism to decrease the harmful amyloid-beta 42 protein (AB42) that forms brain plaques in Alzheimer's disease patients.

According to the study published in the Nov. 8, 2001 issue of the journal Nature, findings suggest that NSAID therapy has a direct impact on the cause of Alzheimer’s disease, which is believed to be the abnormal deposition of AB42 in the brain. This medication offers hope for the development of highly effective plaque-reducing drugs, without the toxic side effects associated with anti-inflammatory medications.

NSAIDs are known to inhibit master enzymes called cyclooxygenases (COX), which control inflammatory responses. It therefore has been assumed by many researchers that NSAIDs are effective in Alzheimer's disease because they reduce the toxic, inflammatory process in the brain. Although some individuals who chronically take NSAIDs have shown reduced risk of developing Alzheimer's disease, the exact mechanism of action of these drugs remains unclear.

The new study is the first to demonstrate a specific pharmacological inhibition of AB42 production. Specifically, the NSAIDs ibuprofen, indomethacin and sulindac sulphide decreased AB42 by as much as 80 percent. However, the results don't mean that physicians should begin to prescribe these three drugs for Alzheimer's patients.

"The dose required to inhibit production of AB42 is far too high. This is a secondary effect of the NSAIDs. For example, a patient would need to take the equivalent of more than 16 tablets of Advil a day," said Edward Koo, M.D., UCSD Department of Neurosciences. "Instead, our findings suggest a new mechanism through which NSAIDs might confer protection from Alzheimer's disease - a mechanism independent of direct anti-inflammatory properties of NSAIDs. "

Since not all NSAIDs are the same, the research team conducted their studies by treating rodent and human cells in laboratory culture dishes with various NSAIDs, then analyzing AB42 levels. While the NSAIDs ibuprofen, indomethacin and sulindac sulphide lowered AB42, other NSAIDs, including aspirin, Naproxen and celecoxib, had no effect on AB42. Similar results were found in studies with mice.

Koo noted that since many researchers and clinicians have proposed that NSAIDs are effective treatments for Alzheimer's disease because they inhibit COX enzymes and therefore inflammation, the UCSD/Mayo team decided to test a new theory. They took cells genetically engineered to lack the COX enzymes and treated them with sulindac. The results showed the reduction of AB42 levels, indicating that a decrease of AB42 levels is completely independent of COX activity.

"These results provide compelling evidence that the reduction in AB42 is not mediated by inhibition of COX activity, the principle mode of action of NSAIDs," the authors stated in the Nature paper.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Ultra ATP+, Double Strength FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
How Glutathione Can Save Your Life How Glutathione Can Save Your Life
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map